Suspect Adverse Drug Events: From Awareness to Opportunity Charity Hudson Jillian Retter Jeffrey...

24
Suspect Adverse Drug Events: From Awareness to Opportunity Charity Hudson Jillian Retter Jeffrey Moore Mid-Year Sales Meeting Bloomington, IN July 13 th – 17 th

Transcript of Suspect Adverse Drug Events: From Awareness to Opportunity Charity Hudson Jillian Retter Jeffrey...

Page 1: Suspect Adverse Drug Events: From Awareness to Opportunity Charity Hudson Jillian Retter Jeffrey Moore Mid-Year Sales Meeting Bloomington, IN July 13 th.

Suspect Adverse Drug Events:

From Awareness to Opportunity

Charity HudsonJillian Retter

Jeffrey MooreMid-Year Sales Meeting

Bloomington, INJuly 13th – 17th

Page 2: Suspect Adverse Drug Events: From Awareness to Opportunity Charity Hudson Jillian Retter Jeffrey Moore Mid-Year Sales Meeting Bloomington, IN July 13 th.

Agenda

Awareness

Reporting

Experiences

Opportunities

Page 3: Suspect Adverse Drug Events: From Awareness to Opportunity Charity Hudson Jillian Retter Jeffrey Moore Mid-Year Sales Meeting Bloomington, IN July 13 th.

Suspect ADEs: Awareness

What is an Adverse Drug Event?

As defined by FDA, 21 CFR 314.80:

“Any adverse event associated with the use of a drug in humans, whether or not considered drug related, including the following: An adverse event occurring in the course of the use of a drug product in professional practice; an adverse event occurring from drug overdose whether accidental or intentional; an adverse event occurring from drug abuse; an adverse event occurring from drug withdrawal; and any failure of expected pharmacological action.”

Page 4: Suspect Adverse Drug Events: From Awareness to Opportunity Charity Hudson Jillian Retter Jeffrey Moore Mid-Year Sales Meeting Bloomington, IN July 13 th.

Suspect ADEs: Awareness

How are Adverse Events classified by FDA?

Serious / Non-Serious

Un-expected / Expected

Page 5: Suspect Adverse Drug Events: From Awareness to Opportunity Charity Hudson Jillian Retter Jeffrey Moore Mid-Year Sales Meeting Bloomington, IN July 13 th.

Suspect ADEs: Awareness

How are Adverse Events classified by FDA?

Serious:

Death

Life-threatening

Hospitalization

Disability

Congenital anomaly

Requires intervention to Prevent Permanent Impairment or Damage

Page 6: Suspect Adverse Drug Events: From Awareness to Opportunity Charity Hudson Jillian Retter Jeffrey Moore Mid-Year Sales Meeting Bloomington, IN July 13 th.

Suspect ADEs: Awareness

How are Adverse Events classified by FDA?

Unexpected / Expected

Unexpected: Not part of the product labeling

Page 7: Suspect Adverse Drug Events: From Awareness to Opportunity Charity Hudson Jillian Retter Jeffrey Moore Mid-Year Sales Meeting Bloomington, IN July 13 th.

Suspect ADEs: Awareness

QUIZ:

Which of the ADEs needs reported?

a. A non-serious, expected event

b. A non-serious, un-expected event

c. A serious, expected event

d. A serious, un-expected event

e. All of the above

Page 8: Suspect Adverse Drug Events: From Awareness to Opportunity Charity Hudson Jillian Retter Jeffrey Moore Mid-Year Sales Meeting Bloomington, IN July 13 th.

Agenda

Awareness

Reporting

Experiences

Opportunities

Page 9: Suspect Adverse Drug Events: From Awareness to Opportunity Charity Hudson Jillian Retter Jeffrey Moore Mid-Year Sales Meeting Bloomington, IN July 13 th.

Suspect ADEs: Reporting

Why do we report suspect ADEs?

Because we are required to do it. (FDA and company policy).

Because if we do not, the customer can report the events straight to FDA, without us even being involved.

Why else?

Because we want to both follow the rules and provide superior service to our customers.

Page 10: Suspect Adverse Drug Events: From Awareness to Opportunity Charity Hudson Jillian Retter Jeffrey Moore Mid-Year Sales Meeting Bloomington, IN July 13 th.

Suspect ADEs: Reporting

What do we absolutely have to report?

identifiable patient

identifiable reporter

at least one suspected active substance/product

at least one suspected adverse reaction

Page 11: Suspect Adverse Drug Events: From Awareness to Opportunity Charity Hudson Jillian Retter Jeffrey Moore Mid-Year Sales Meeting Bloomington, IN July 13 th.

Suspect ADEs: Reporting

How?

Call / Text / e-mail Charity

Do I or my customers have to use the form?

Not necessarily

When?

ASAP

Page 12: Suspect Adverse Drug Events: From Awareness to Opportunity Charity Hudson Jillian Retter Jeffrey Moore Mid-Year Sales Meeting Bloomington, IN July 13 th.

Suspect ADEs: Reporting

Why do we need to report ASAP?

Completion of forms

Submission to HQ

HQ creation of formal report

Submission to FDA

Many factors involved in appropriately reporting.

Your front line help ensures a smooth system, both for customer and for USHQ and HQ.

Page 13: Suspect Adverse Drug Events: From Awareness to Opportunity Charity Hudson Jillian Retter Jeffrey Moore Mid-Year Sales Meeting Bloomington, IN July 13 th.

Suspect ADEs: Reporting

Questions about reporting?

Page 14: Suspect Adverse Drug Events: From Awareness to Opportunity Charity Hudson Jillian Retter Jeffrey Moore Mid-Year Sales Meeting Bloomington, IN July 13 th.

Agenda

Awareness

Reporting

Experiences

Opportunities

Page 15: Suspect Adverse Drug Events: From Awareness to Opportunity Charity Hudson Jillian Retter Jeffrey Moore Mid-Year Sales Meeting Bloomington, IN July 13 th.

Suspect ADEs: Experiences

Jill Retter

Arlington Memorial Hospital

Hexabrix

Management of the situation:

Education

Reporting

Closed sale

Page 16: Suspect Adverse Drug Events: From Awareness to Opportunity Charity Hudson Jillian Retter Jeffrey Moore Mid-Year Sales Meeting Bloomington, IN July 13 th.

Suspect ADEs: Experiences

Jeffrey Moore

West Suburban Hospital, Oak Park

Hexabrix

Management of the situation:

Looked into the situation further…

Education

Reporting

Customer Service

Page 17: Suspect Adverse Drug Events: From Awareness to Opportunity Charity Hudson Jillian Retter Jeffrey Moore Mid-Year Sales Meeting Bloomington, IN July 13 th.

Agenda

Awareness

Reporting

Experiences

Opportunities

Page 18: Suspect Adverse Drug Events: From Awareness to Opportunity Charity Hudson Jillian Retter Jeffrey Moore Mid-Year Sales Meeting Bloomington, IN July 13 th.

Suspect ADEs: Opportunities

Where?

At all facilities, in all situations

How?

Customer Service by MCP

Customer Service by USHQ

Management of the situation:

Educate

Report the event

Follow Up

Page 19: Suspect Adverse Drug Events: From Awareness to Opportunity Charity Hudson Jillian Retter Jeffrey Moore Mid-Year Sales Meeting Bloomington, IN July 13 th.

Suspect ADEs: Opportunities

Management of the situation:

Assess the situation

Utilize your experience, clinical knowledge and sales skills to determine the next course of action

Commit to the customer to reporting the event

Report the event to USHQ

Follow Up with the customer

Page 20: Suspect Adverse Drug Events: From Awareness to Opportunity Charity Hudson Jillian Retter Jeffrey Moore Mid-Year Sales Meeting Bloomington, IN July 13 th.

Suspect ADEs: Opportunities

Why?

Provide excellent Customer and Patient Care

Demonstrate Guerbet’s commitment to appropriate reporting

Maintain Competitive Advantage

Learn more about your customer and your products

Page 21: Suspect Adverse Drug Events: From Awareness to Opportunity Charity Hudson Jillian Retter Jeffrey Moore Mid-Year Sales Meeting Bloomington, IN July 13 th.

Suspect ADEs: Opportunities

Why?

Scenario:

Page 22: Suspect Adverse Drug Events: From Awareness to Opportunity Charity Hudson Jillian Retter Jeffrey Moore Mid-Year Sales Meeting Bloomington, IN July 13 th.

Suspect ADEs:

Why?

Page 23: Suspect Adverse Drug Events: From Awareness to Opportunity Charity Hudson Jillian Retter Jeffrey Moore Mid-Year Sales Meeting Bloomington, IN July 13 th.

Questions?

Page 24: Suspect Adverse Drug Events: From Awareness to Opportunity Charity Hudson Jillian Retter Jeffrey Moore Mid-Year Sales Meeting Bloomington, IN July 13 th.